1 terminated. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
Follow Heart Decompensation: new trials by email Literature Review of Heart Decompensation trials Research Report on Heart Decompensation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase IIb Study to Investigate the Efficacy and Tolerability of Cinaciguat (150 µg/h, 100 µg/h, 50 µg/h) Given Intravenously to Subjects With Acute Decompensated Chronic Congestive Heart Failure (ADHF) Cinaciguat (BAY58-2667), Placebo - Heart Failure, Heart Decompensation | Phase 2 | Terminated | Bayer | 62 | 2010-04-01 | 2015-10-08 |
Heart Failure (1)
Cardiovascular Diseases (1) · Heart Diseases (1)
BAY 58-2667 (1)
Bayer (1)
Canada (1) · Czechia (1) · Finland (1) · France (1) · Germany (1) · Hungary (1) · Ireland (1) · Israel (1) · Italy (1) · Japan (1) · Poland (1) · South Africa (1) · South Korea (1) · Spain (1) · United Kingdom (1)
2009 (1)